SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]:
SEC Accession No. 0001062993-20-001304
Filing Date
2020-03-10
Accepted
2020-03-10 07:06:14
Documents
89
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 40-F form40f.htm 40-F 36843
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 343404
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 319541
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 591761
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 5682
6 EXHIBIT 99.5 exhibit99-5.htm EX-99.5 5694
7 EXHIBIT 99.6 exhibit99-6.htm EX-99.6 2161
8 EXHIBIT 99.7 exhibit99-7.htm EX-99.7 2031
9 EXHIBIT 99.8 exhibit99-8.htm EX-99.8 3978
16 GRAPHIC exhibit99-1x001.jpg GRAPHIC 12416
17 GRAPHIC exhibit99-1x002.jpg GRAPHIC 28932
18 GRAPHIC exhibit99-1x003.jpg GRAPHIC 68855
19 GRAPHIC exhibit99-2x001.jpg GRAPHIC 12135
20 GRAPHIC exhibit99-2x002.jpg GRAPHIC 28932
21 GRAPHIC exhibit99-2x003.jpg GRAPHIC 68855
22 GRAPHIC exhibit99-1x1x1.jpg GRAPHIC 22589
  Complete submission text file 0001062993-20-001304.txt   5871973

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE tril-20191231.xml EX-101.INS 1114087
11 XBRL SCHEMA FILE tril-20191231.xsd EX-101.SCH 82352
12 XBRL CALCULATION FILE tril-20191231_cal.xml EX-101.CAL 42013
13 XBRL DEFINITION FILE tril-20191231_def.xml EX-101.DEF 154867
14 XBRL LABEL FILE tril-20191231_lab.xml EX-101.LAB 458045
15 XBRL PRESENTATION FILE tril-20191231_pre.xml EX-101.PRE 310623
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 40-F | Act: 34 | File No.: 001-36596 | Film No.: 20699900
SIC: 2834 Pharmaceutical Preparations